Literature DB >> 17549043

Dimethyl sulphoxide relaxes rabbit detrusor muscle by decreasing the Ca2+ sensitivity of the contractile apparatus.

K-i Shiga1, K Hirano, J Nishimura, N Niiro, S Naito, H Kanaide.   

Abstract

BACKGROUND AND
PURPOSE: The intravesical administration of dimethyl sulphoxide (DMSO) is used to alleviate the symptoms of interstitial cystitis. We investigated the relaxant effect of DMSO and its underlying mechanism in the detrusor muscle. EXPERIMENTAL APPROACH: The effects of DMSO on contraction, on Ca2+ sensitivity of myofilaments, and on myosin light chain (MLC) phosphorylation were investigated in both intact and alpha-toxin-permeabilized strips of rabbit detrusor muscle. KEY
RESULTS: In fura-PE3-loaded strips, DMSO (>1%) induced a significant relaxation during sustained contractions induced by 60 mM K+-depolarization or 10 microM carbachol, while having no effect on the [Ca2+](i) level. DMSO decreased the level of MLC phosphorylation during the contractions induced by 60 mM K+ and 10 microM carbachol. DMSO also inhibited both the contraction and MLC phosphorylation induced by calyculin-A in intact strips. In the alpha-toxin-permeabilized preparations, DMSO relaxed the Ca2+-induced contraction and also inhibited the tension development induced by a stepwise increment of Ca2+ concentrations. Such a relaxant effect of DMSO was enhanced in the presence of phosphate. CONCLUSIONS AND IMPLICATIONS: DMSO relaxes rabbit detrusor muscle by decreasing the Ca2+ sensitivity of myofilaments. Inhibition of the kinase activities involved in myosin phosphorylation may play a major role in DMSO-induced Ca2+ desensitization. Inhibition of the cross-bridge cycling at the step of phosphate release may also contribute to the relaxant effect of DMSO. Such relaxant effects of DMSO could be linked to the therapeutic effect of DMSO in interstitial cystitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17549043      PMCID: PMC2042939          DOI: 10.1038/sj.bjp.0707317

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Regional variation in myosin isoforms and phosphorylation at the resting tone in urinary bladder smooth muscle.

Authors:  J A Hypolite; M E DiSanto; Y Zheng; S Chang; A J Wein; S Chacko
Journal:  Am J Physiol Cell Physiol       Date:  2001-02       Impact factor: 4.249

2.  NH2-terminal fragments of the 130 kDa subunit of myosin phosphatase increase the Ca2+ sensitivity of porcine renal artery.

Authors:  Y Zhou; K Hirano; C Sakihara; J Nishimura; H Kanaide
Journal:  J Physiol       Date:  1999-04-01       Impact factor: 5.182

Review 3.  Protein kinase network in the regulation of phosphorylation and dephosphorylation of smooth muscle myosin light chain.

Authors:  Katusya Hirano; Dmitry N Derkach; Mayumi Hirano; Junji Nishimura; Hideo Kanaide
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

4.  Expression of beta3-adrenoceptors in rat detrusor smooth muscle.

Authors:  H Seguchi; J Nishimura; Y Zhou; N Niiro; J Kumazawa; H Kanaide
Journal:  J Urol       Date:  1998-06       Impact factor: 7.450

5.  Norepinephrine and GTP-gamma-S increase myofilament Ca2+ sensitivity in alpha-toxin permeabilized arterial smooth muscle.

Authors:  J Nishimura; M Kolber; C van Breemen
Journal:  Biochem Biophys Res Commun       Date:  1988-12-15       Impact factor: 3.575

6.  Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis--a practical approach.

Authors:  J Parkin; C Shea; G R Sant
Journal:  Urology       Date:  1997-05       Impact factor: 2.649

7.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

8.  Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis: discomfort, side-effects and treatment outcome.

Authors:  Josefine Rössberger; Magnus Fall; Ralph Peeker
Journal:  Scand J Urol Nephrol       Date:  2005

9.  Dimethyl sulphoxide enhances the effects of P(i) in myofibrils and inhibits the activity of rabbit skeletal muscle contractile proteins.

Authors:  A C Mariano; G M Alexandre; L C Silva; A Romeiro; L C Cameron; Y Chen; P B Chase; M M Sorenson
Journal:  Biochem J       Date:  2001-09-15       Impact factor: 3.857

10.  Cooperative attachment of cross bridges predicts regulation of smooth muscle force by myosin phosphorylation.

Authors:  Christopher M Rembold; Robert L Wardle; Christopher J Wingard; Timothy W Batts; Elaine F Etter; Richard A Murphy
Journal:  Am J Physiol Cell Physiol       Date:  2004-05-19       Impact factor: 4.249

View more
  10 in total

1.  Dimethyl sulfoxide inhibits spontaneous oocyte fragmentation and delays inactivation of maturation promoting factor (MPF) during the prolonged culture of ovulated murine oocytes in vitro.

Authors:  Taesaeng Choi
Journal:  Cytotechnology       Date:  2011-02-20       Impact factor: 2.058

2.  Intravesical dimethyl sulfoxide inhibits acute and chronic bladder inflammation in transgenic experimental autoimmune cystitis models.

Authors:  Ronald Kim; Wujiang Liu; Xiaohong Chen; Karl J Kreder; Yi Luo
Journal:  J Biomed Biotechnol       Date:  2010-11-11

Review 3.  Current recommendations for bladder instillation therapy in the treatment of interstitial cystitis/bladder pain syndrome.

Authors:  Marc A Colaco; Robert J Evans
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

4.  Herpes simplex virus vector-mediated gene delivery for the treatment of lower urinary tract pain.

Authors:  W F Goins; J R Goss; M B Chancellor; W C de Groat; J C Glorioso; N Yoshimura
Journal:  Gene Ther       Date:  2009-02-26       Impact factor: 5.250

Review 5.  Intravesical treatments of bladder pain syndrome/interstitial cystitis.

Authors:  Jochen Neuhaus; Thilo Schwalenberg
Journal:  Nat Rev Urol       Date:  2012-11-27       Impact factor: 14.432

6.  Differential effects of TRPM4 channel inhibitors on Guinea pig urinary bladder smooth muscle excitability and contractility: Novel 4-chloro-2-[2-(2-chloro-phenoxy)-acetylamino]-benzoic acid (CBA) versus classical 9-phenanthrol.

Authors:  John Malysz; Sarah E Maxwell; Georgi V Petkov
Journal:  Pharmacol Res Perspect       Date:  2022-08

7.  Effect of Electroacupuncture on Bladder Dysfunction via Regulation of MLC and MLCK Phosphorylation in a Rat Model of Type 2 Diabetes Mellitus.

Authors:  Xuke Han; Yang Gao; Xuan Yin; Shengju Wang; Xiaoran Zhang; Qiu Chen
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-10       Impact factor: 2.629

Review 8.  Review of intravesical therapies for bladder pain syndrome/interstitial cystitis.

Authors:  Kristina Cvach; Anna Rosamilia
Journal:  Transl Androl Urol       Date:  2015-12

9.  Therapeutic Endoscopic Treatment Plus Maintenance Dimethyl Sulfoxide Therapy Prolongs Recurrence-Free Time in Patients With Hunner Type Interstitial Cystitis: A Pilot Study.

Authors:  Atsushi Otsuka; Takahisa Suzuki; Yuto Matsushita; Hiromitsu Watanabe; Keita Tamura; Daisuke Motoyama; Toshiki Ito; Takayuki Sugiyama; Hideaki Miyake
Journal:  Int Neurourol J       Date:  2019-12-31       Impact factor: 2.835

Review 10.  Therapeutic Efficacy of onabotulinumtoxinA Delivered Using Various Approaches in Sensory Bladder Disorder.

Authors:  Po-Yen Chen; Wei-Chia Lee; Hung-Jen Wang; Yao-Chi Chuang
Journal:  Toxins (Basel)       Date:  2020-01-23       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.